# FDA Inspection 1304312 - Aurobindo Pharma Limited - February 10, 2026

Source: https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-limited/f603cc93-dc47-4606-8cf0-0dde6af906da/
Source feed: FDA_Inspections

> FDA Inspection 1304312 for Aurobindo Pharma Limited on February 10, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304312
- Company Name: Aurobindo Pharma Limited
- Inspection Date: 2026-02-10
- Product Type: Human Drugs
- Office Name: Office of Inspections and Investigations

## Related Documents

- [FDA Inspection 1169446 - 2022-05-10](https://www.globalkeysolutions.net/api/records/fda_inspections/aurobindo-pharma-limited/b9201ac7-5ec4-46dd-8aaf-7304c3c93094/)
- [FDA Inspection 1105823 - 2019-09-27](https://www.globalkeysolutions.net/api/records/fda_inspections/aurobindo-pharma-limited/65ccbba1-8a36-41aa-99c4-64321edccdd9/)
- [FDA Inspection 1022788 - 2017-06-24](https://www.globalkeysolutions.net/api/records/fda_inspections/aurobindo-pharma-limited/8d9ab63f-c6f2-4237-89f8-eb13c0866d60/)
- [FDA Inspection 927596 - 2015-03-13](https://www.globalkeysolutions.net/api/records/fda_inspections/aurobindo-pharma-limited/6c7e4565-5d73-4395-b181-5abaff503b71/)
- [FDA Inspection 787128 - 2012-06-19](https://www.globalkeysolutions.net/api/records/fda_inspections/aurobindo-pharma-limited/90d9c974-e3d8-49ad-961f-4caba97a4429/)

Company: https://www.globalkeysolutions.net/companies/aurobindo-pharma-limited/95bcc3b3-09a1-4249-af2f-5c83de789b76

Office: https://www.globalkeysolutions.net/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8